New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics
Bondareva, N.S.; Budanov, S.V.
Antibiotiki i Khimioterapiia 43(8): 28-33
1998
ISSN/ISBN: 0235-2990 PMID: 9777103 Document Number: 493334
Document emailed within 1 workday
Related Documents
Kwaik, Y.A. 2000: ASM - 100th Meeting. Fluoroquinolones and other antimicrobial agents IDrugs: the investigational drugs journal 3(8): 865-867Iakovlev, V.P.; Izotova, G.N.; Iakovlev, S.V. 1997: The pharmacokinetics of fluoroquinolones in different diseases Antibiotiki i Khimioterapiia 42(1): 23-29
Bergeron, M.G. 1989: The pharmacokinetics and tissue penetration of the fluoroquinolones Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(1): 20-27
Akinyemi, K.O.; Bamiro, B.S.; Coker, A.O. 2007: Salmonellosis in Lagos, Nigeria: incidence of Plasmodium falciparum-associated co-infection, patterns of antimicrobial resistance, and emergence of reduced susceptibility to fluoroquinolones Journal of Health Population and Nutrition 25(3): 351-358
Sams, R.A. 1984: Principles of clinical pharmacokinetics of antimicrobial drugs Journal of the American Veterinary Medical Association 185(10): 1068-1071
Budanov, S.V.; Smirnova, L.B. 2001: Levofloxacin (Tavanic)--a novel quinolone of the IIi generation. Antimicrobial activity, pharmacokinetics, clinical significance Antibiotiki i Khimioterapiia 46(5): 31-38
Sato, N.; Suzuki, H.; Hayashi, H.; Shibasaki, S.; Sugano, T.; Maebashi, K.; Kurosawa, T.; Shiomi, M.; Ogata, H. 2008: New concept and a theoretical consideration of the mechanism-based pharmacokinetics/ pharmacodynamics (PK/PD) modeling for antimicrobial agents Japanese Journal of Antibiotics 61(5): 314-338
Wang, X.F.; Jiang, S.C.; Wei, Y.L. 1990: Effect of fluoroquinolones made in China in the treatment of acute bacillary dysentery. A report of 212 cases Zhonghua Nei Ke Za Zhi 29(8): 482
Paganini, H.; Marin, M. 2002: Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin Medicina 62(Suppl 2): 52-55
Sun, Y.-f.; Fan, Y.-y.; Huang, Y.-f.; Wang, M.; Lu, X.-x. 2013: Antimicrobial resistance and virulence characteristics of Vibrio parahaemolyticus Zhonghua Yi Xue Za Zhi 93(34): 2733-2735
Zapadniuk, V.I. 1984: Characteristics of pharmacokinetics during aging and its correction Vrachebnoe Delo 1984(4): 41-44
Korkushko, O.V.; Orlov, P.A. 1979: Age-related characteristics of digoxin pharmacokinetics Terapevticheskii Arkhiv 51(3): 85-88
Inoue, M. 1998: Microbiological characteristics in Japan. Antimicrobial resistance and susceptibility patterns International Journal of Hematology 68(Suppl 1): S13-S14
Wasteson, U.; Hvaal, A.B.; Sørum, H.; Myhr, E.; Fossum, K. 1989: Antibacterial spectrum and some other characteristics of an antimicrobial factor produced by Yersinia ruckeri Acta Veterinaria Scandinavica 30(3): 253-257
Gullberg, R. 1974: The B12-binding protein in granulocytes and external secretions--characteristics and a possible selective antimicrobial function Lakartidningen 71(21): 2189-2191
Fish, D.N.; Piscitelli, S.C.; Danziger, L.H. 1995: Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies PharmacoTherapy 15(3): 279-291
Loginov, A.S.; Sil'vestrova, S.I.; Bendikov, E.A.; Giliadova, L.A. 1990: The characteristics of gastrozepin pharmacokinetics in patients with gastric and duodenal peptic ulcers Farmakologiia i Toksikologiia 53(1): 43-45
Sikora, A.; Kozioł-Montewka, M.; Bogut, A. 2011: The characteristics of Gram-positive bacteria isolated from skin lesions observed in ambulatory patients and the assessment of their susceptibility to antimicrobial drugs Przeglad Lekarski 68(4): 196-201
Kuwabara, Y.; Komuro, I. 2007: ACE inhibitor: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 5): 66-73
Yukawa, E.; Mine, H.; Higuchi, S.; Aoyama, T. 1992: Digoxin population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens Journal of Pharmacy and Pharmacology 44(9): 761-765